Morningstar Investor users sign in here.

Company Profile

  • Business description

    Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

  • Contact

    2600 Kelly Road
    Suite 100
    Warrington PA 18976-3622
    USA

    T: +1 215 488-9300

    E: ir@discoverylabs.com

    https://www.windtreetx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    20

Stocks News & Analysis

video

Top opportunities in the Aussie tech and AI space

Morningstar's Michael Malseed interviews First Sentier's Dawn Kanelleas and Maple-Brown Abbott's Phil Hudak. 
stocks

3 wide moat shares at five-star prices

Our analysts think these companies enjoy durable competitive advantages with the potential to last for at least 20 years. The shares also look cheap.
stocks

Undervalued ASX share bolsters acquisition firepower

We recommend shareholders participate in equity raise.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,015.80 72.20 0.91%
CAC 40 7,616.90 45.33 0.60%
DAX 40 18,153.78 85.57 0.47%
Dow JONES (US) 38,778.10 188.94 0.49%
FTSE 100 8,178.26 36.11 0.44%
HKSE 17,915.55 20.57 -0.11%
NASDAQ 17,857.02 168.14 0.95%
Nikkei 225 38,482.11 379.67 1.00%
NZX 50 Index 11,767.40 68.89 0.59%
S&P 500 5,473.23 41.63 0.77%
S&P/ASX 200 7,778.10 77.80 1.01%
SSE Composite Index 3,030.25 14.36 0.48%

Market Movers

Name
Last price
Change
% Change
Fortescue Ltd FMG 21.79 1.19 -5.18%
Melbana Energy Ltd MAY 0.05 0.02 -31.82%
Pilbara Minerals Ltd PLS 3.26 0.12 3.82%
Core Lithium Ltd CXO 0.09 0.00 3.45%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Telstra Group Ltd TLS 3.60 0.05 1.41%
Beach Energy Ltd BPT 1.53 0.04 -2.24%
Imugene Ltd IMU 0.06 0.00 -3.45%
Red 5 Ltd RED 0.45 0.01 -1.10%
South32 Ltd S32 3.64 0.02 0.55%